Branched acrylate functional oligomers

Patent metadata

Field	Value
Publication number	US-2025011524-A1
Application number	US-202218695897-A
Country	US
Kind code	A1
Filing date	Sep 28, 2022
Priority date	Sep 30, 2021
Publication date	Jan 9, 2025
Grant date	—

Abstract

A curable oligomer is the reaction product of: x equivalents of at least one diepoxy a); y1 equivalents of at least one unsaturated carboxylic acid b); and y2 equivalents of at least one polycarboxylic acid c) comprising at least three carboxylic acid groups. x is defined as the number of moles of epoxy groups in component a), y1 is defined as the number of moles of carboxylic acid groups in component b), and y2 is defined as the number of moles of carboxylic acid groups in component c).

First claim

1 . A curable oligomer comprising the reaction product of:
x equivalents of a component a) comprising at least one diepoxy; y1 equivalents of a component b) comprising at least one unsaturated carboxylic acid; and y2 equivalents of a component c) comprising at least one polycarboxylic acid bearing at least three carboxylic acid groups;
wherein x is the number of moles of epoxy groups in component a), y1 is the number of moles of carboxylic acid groups in component b), and y2 is the number of moles of carboxylic acid groups in component c); and
the ratio of x:(y1+y2) is from 1:1.1 to 1:0.90.

2 . The curable oligomer of claim 1 , wherein the ratio of y2:x is at most 1:4.

3 . The curable oligomer of claim 1 , wherein ratio of y2:y1 is at most 1:1.5.

4 . The curable oligomer of claim 1 , wherein component a) comprises at least one compound selected from an aliphatic diepoxy, a bisphenol-based diglycidyl ether and combinations thereof.

5 . The curable oligomer of claim 1 , wherein component a) comprises at least one aromatic diepoxy.

6 . The curable oligomer of claim 1 , wherein component a) comprises at least one aliphatic diglycidyl ether.

7 . The curable oligomer of claim 1 , wherein component a) comprises at least one compound selected from 1,4-butanediol diglycidyl ether, 1,3-butanediol diglycidyl ether, 1,6-hexanediol diglycidyl ether, neopentyl glycol diglycidyl ether, ethylene glycol diglycidyl ether a polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, a polypropylene glycol diglycidyl ether, 1,2- or 1,4-cyclohexanedimethanol diglycidyl ether, hydrogenated bisphenol A diglycidyl ether, bisphenol-A-diglycidyl ether, bisphenol-AP-diglycidyl ether, bisphenol-AF-diglycidyl ether, bisphenol-B-diglycidyl ether, bisphenol-BP-diglycidyl ether, bisphenol-C-diglycidyl ether, bisphenol-C2-diglycidyl ether, bisphenol-F-diglycidyl ether, bisphenol-G-diglycidyl ether, bisphenol-M-diglycidyl ether, bisphenol-S-diglycidyl ether, bisphenol-P-diglycidyl ether, bisphenol-PH-diglycidyl ether, bisphenol-TMC-diglycidyl ether, bisphenol-Z-diglycidyl ether, dinitrobisphenol-A-diglycidyl ether, tetrabromobisphenol-A-diglycidyl ether and combinations thereof.

8 . The curable oligomer of claim 1 , wherein component b) comprises an α-β ethylenically unsaturated carboxylic acid.

9 . The curable oligomer of claim 1 , wherein component b) comprises at least one compound selected from acrylic acid, methacrylic acid, ethacrylic acid, crotonic acid, isocrotonic acid, angelic acid, tiglic acid, senecioic acid, acryloyloxypropionic acid, maleic acid, fumaric acid, or itaconic acid or combinations thereof.

10 . The curable oligomer of claim 1 , wherein component c) comprises a carboxylic acid bearing at least four carboxylic acid groups.

11 . The curable oligomer of claim 1 , wherein component c) comprises a mixture of at least one tricarboxylic acid and at least one tetracarboxylic acid.

12 . The curable oligomer of claim 1 , wherein component c) comprises at least one compound selected from citric acid; isocitric acid; 1,2,3-propanetricarboxylic acid; 1,2,4-butanetricarboxylic acid; 1,2,3,4 butane tetracarboxylic acid; 1,2,3,4-cyclobutanetetracarboxylic acid; 1,2,3,4-cyclopentanetetracarboxylic acid; 1,3,5-cyclohexanetricarboxylic acid; 1,2,4,5-cyclohexanetetracarboxylic acid; 1,3,5 benzenetricarboxylic acid; 1,2,4-benzenetricarboxylic acid; 1,2,4,5-benzenetetracarboxylic acid; 1,3,5,7-adamantane tetracarboxylic acid; 1,3,5,7 adamantane tetrabenzoic acid and combinations thereof.

13 . The curable oligomer of claim 1 , wherein the total weight of residues derived from the reaction of components a), b) and c) represents at least 90% of the total weight of the curable oligomer.

14 . A curable composition comprising the curable oligomer of claim 1 and at least one inhibitor and/or at least one ethylenically unsaturated compound other than the curable oligomer.

15 . A method of preparing a curable oligomer, wherein the method comprises reacting a mixture comprising:
x equivalents of a component a) comprising at least one diepoxy; y2 equivalents of a component c) comprising at least one polycarboxylic acid bearing at least three carboxylic acid groups; and optionally z1 equivalents of a component b) comprising at least one unsaturated carboxylic acid;
to provide an epoxy-capped prepolymer;
and then reacting the epoxy-capped prepolymer with z2 equivalents of a component b) comprising at least one unsaturated carboxylic acid;
wherein z1+z2=y1,
x is the number of moles of epoxy groups in component a), y1 is the number of moles of carboxylic acid groups in component b), and y2 is the number of moles of carboxylic acid groups in component c).

16 . The method of claim 15 , wherein the ratio of x:(y1+y2) is from 1:1.1 to 1:0.90.

17 . A method of preparing a curable oligomer, wherein the method comprises reacting a mixture comprising:
x equivalents of a component a) comprising at least one diepoxy; y1 equivalents of a component b) comprising at least one unsaturated carboxylic acid; and y2 equivalents of a component c) comprising at least one polycarboxylic acid bearing at least three carboxylic acid groups,
to provide a curable oligomer;
wherein x is the number of moles of epoxy groups in component a), y1 is the number of moles of carboxylic acid groups in component b), and y2 is the number of moles of carboxylic acid groups in component c), the ratio of x:(y1+y2) is from 1:1.1 to 1:0.90.

18 . The method of claim, wherein the ratio of y2:x is at most 1:4.

19 . The method of claim 15 to 18 , wherein component a) comprises at least one compound selected from an aliphatic diepoxy, a bisphenol-based diglycidyl ether and combinations thereof.

Assignees

• Arkema France

Inventors

• Li Ling
• He Yuhong
• Shurdha Endrit

Classifications

• C08G59/688

  containing phosphorus · CPC title

• C08G59/686

  containing nitrogen · CPC title

• C08G59/4292

  together with monocarboxylic acids · CPC title

• C08G59/4207

  aliphatic · CPC title

• C08G59/1466 Primary

  Acrylic or methacrylic acids · CPC title